Delta Waves and Cognitive Recovery
RECOPS
2 other identifiers
interventional
45
1 country
1
Brief Summary
In a laboratory protocol in healthy adults, exposed to a prolonged period of wakefulness with a restricted opportunity for sleep (40h of wakefulness / 3h of sleep / 21h of wakefulness), we hypothesize that the relative increase in spectral power of Delta waves \[ 1 - 4 Hz\] in NREM in the frontal territory, identified as a potential marker of the restorative function of sleep, during a night of sleep with limited recovery (3 h of time in bed) after sleep deprivation (40 h of continuous wakefulness), will be less important in subjects with poor recovery in terms of cognitive performance than in those with good recovery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 12, 2023
CompletedFirst Posted
Study publicly available on registry
June 29, 2023
CompletedStudy Start
First participant enrolled
October 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2024
CompletedJune 24, 2024
June 1, 2024
6 months
June 12, 2023
June 19, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Delta power
EEG Delta power in Hz
One night
Secondary Outcomes (1)
Cognitive performance
2 days
Study Arms (1)
Sleep
EXPERIMENTALSleep deprivation
Interventions
Eligibility Criteria
You may qualify if:
- Healthy volunteer man or woman
- Between 18 and 45 years of age
- Having given written consent after having been informed of the terms of the study and the objectives of the genetic analysis performed
You may not qualify if:
- Current medical treatment
- Chronic medical pathology, (psychol, cardiovascular or respiratory, sleep disorders)
- Pregnancy
- Sleep disorder
- Extreme chronotype
- Excessive daytime sleepiness
- Suspicion of anxiety or depressive disorder
- Estimated caffeine consumption \> 200mg/day
- Not covered by a health insurance
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Institut de Recherche Biomedicale des Armeeslead
- Hotel Dieu de France Hospitalcollaborator
- University of Paris 5 - Rene Descartescollaborator
Study Sites (1)
Institut de recherche biomédical des armées
Brétigny-sur-Orge, 91220, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 12, 2023
First Posted
June 29, 2023
Study Start
October 1, 2023
Primary Completion
March 30, 2024
Study Completion
April 30, 2024
Last Updated
June 24, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share